-
Expression profiling improves risk assessment for pediatric ALL
-
Dissecting p53 tumor suppressor functions in vivo
-
Stable suppression of tumorigenicity by RNA interference
-
BCR-ABL kinase domain mutations confer resistance to imatinib
-
Distinct BH3 domains promote apoptosis by different mechanisms
-
Hypoxia-induced Met activation drives tumor cell dissemination
-
A multigenic program mediating breast cancer metastasis to bone
-
-
Puma mediates p53-dependent and –independent cell death
-
Modeling and detecting ductal pancreatic cancer in mice
-
HOXB13:IL17BR predicts relapse in early stage ER+ breast cancer
-
The LKB1 tumor suppressor negatively regulates mTOR signaling
-
Microenvironmental changes during breast tumor progression
-
Loss of PTEN predicts trastuzumab resistance
-
Vascular normalization governs brain tumor response to radiation
-
Succinate conveys an oncogenic signal in TCA cycle-impaired cells
-
Nilotinib, a selective inhibitor of native and mutant Bcr-Abl
-
JAK2V617F mutations in myeloproliferative disorders
-
B cells foster squamous carcinogenesis
-
Tensional homeostasis and the malignant phenotype
-
-
MicroRNAs identify lung cancer histological types and prognosis
-
Epigenetic therapy upregulates microRNA expression
-
ABT-737 efficiently induces apoptosis if Mcl-1 is neutralized
-
Sensitivity and resistance to BH3 mimetic ABT-737
-
A panel of cell lines models functional breast cancer subtypes
-
Normalization of glioblastoma vasculature in patients
-
A brain tumor stem cell niche
-
Molecular definition of breast tumor heterogeneity
-
Mutations in the noncanonical NF-kappaB pathway in MM
-
Classical and alternative NF-kappaB pathways in multiple myeloma
-
Systemic spread in an early step in breast cancer
-
HIF-1 regulated tumorigenesis by recruiting BMDCs
-
-
Inhibition of premature senescence by Twist
-
-
IL-6-Stat3 signaling in colitis-associated cancer
-
Brief antiangiogenic therapy increases metastasis
-
Malignant progression in angiogenesis inhibition
-
Immune regulation of mammary cancer metastasis
-
Polarization of tumor-associated neutrophils by TGF-beta
-
Genomic Alterations in Clinical GBM Subtypes
-
IDH1 and IDH2 Mutations in AML Generate 2HG
-
CpG Island Methylator Phenotype in Gliomas
-
Genomic Characterization of Human Prostate Cancers
-
IDH1/2 Mutations Perturb DNA Methylation in AML
-
-
2-HG is an antagonist of alpha-KG
-
-
SIRT3 reprograms cell metabolism through HIF1alpha
-
Platelet-to-tumor cell signals promote metastasis
